Services Overview

Enabling pulmonary drug discovery.

In tackling its own unique formulation problems, Pulmokine has developed a patent pending inhalation system and preclinical efficacy solutions that we are making available to the pulmonary drug development community.

These include both fee-based services and products/tools:

  • Patent pending method to neutralize low pH solutions for inhalation
  • Lab animals equipped for ambulatory monitoring of pulmonary artery pressure via telemetry
  • Techniques for measurement of lung function as well as heart function
  • Performance of pre-clinical animal testing: proven system for inhalation studies
  • Pre-clinical animal models of pulmonary hypertension (PAH)